Home

Divis Laboratories Ltd PE Ratio

Image

Divis Laboratories Ltd

NSE: DIVISLAB

PE

76.6

Last updated on: Feb 12, 2025

Key Highlights

  • The P/E Ratio of Divis Laboratories Ltd is 76.6 as of 12 Feb 15:30 PM .
  • The P/E Ratio of Divis Laboratories Ltd changed from 38.3 on March 2020 to 56.9 on March 2024 . This represents a CAGR of 8.24% over 5 years.
  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 5966 as of 12 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Divis Laboratories Ltd

No data available

Company Fundamentals for Divis Laboratories Ltd

Image

Divis Laboratories Ltd

NSE: DIVISLAB

Share Price

₹ 5966.65

17.50 (0.29%)

stock direction

Last updated on: Feb 12, 2025

Market Price of Divis Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Divis Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Feb 20255966.65
11 Feb 20255949.15
10 Feb 20255931
07 Feb 20256140.45
06 Feb 20256116.9
05 Feb 20256124.4
04 Feb 20256092.2
03 Feb 20255889.3
01 Feb 20255622.3
31 Jan 20255575.9

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Divis Laboratories Ltd

Asset Value vs Market Value of Divis Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Divis Laboratories Ltd158395
Sun Pharmaceuticals Industries Ltd406363
Cipla Ltd117088
Torrent Pharmaceuticals Ltd103663
Dr Reddys Laboratories Ltd101458
Mankind Pharma Ltd99897

PE Ratio of Divis Laboratories Ltd Explained

158395

Market cap

2067

Earnings

76.6X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Divis Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Divis Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Divis Laboratories Ltd

No data available

* All values are in %

About Divis Laboratories Ltd

  • Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

Divis Laboratories Ltd News Hub

Divis Laboratories Ltd rises for third straight session

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at Rs 4884.75,

Read more

21 Aug 24

Divis Lab Q1 PAT climbs 21% YoY to Rs 430 cr

Revenue from operations grew by 19.12% year on year to Rs 2,118 crore in the quarter ended 30 June 2

Read more

03 Aug 24

Divi's Laboratories consolidated net profit rises 20.79% in the June 2024 quarter

Net profit of Divi's Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June 2024 as a

Read more

03 Aug 24

Divis Laboratories Ltd up for third straight session

Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 5151.7,

Read more

05 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Divis Laboratories Ltd

What is the current PE Ratio of Divis Laboratories Ltd?

The Current PE Ratio of Divis Laboratories Ltd is 76.63 as on 12 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Feb 2025.

What was the PE Ratio of Divis Laboratories Ltd last year?

The PE Ratio of Divis Laboratories Ltd was 41.05 last year, now the PE ratio is 76.63, showing a year-on-year growth of 86.7%.

What does the PE Ratio of Divis Laboratories Ltd indicate about its stock?

The PE Ratio of Divis Laboratories Ltd is 76.63. This ratio indicates that investors are willing to pay 76.63 times the earnings per share for each share of Divis Laboratories Ltd.

What is the PE Ratio Growth of Divis Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Divis Laboratories Ltd grew by 86.7% whereas, the EPS ratio grew by 15.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions